Trump cites GLP-1 savings in diabetes message

President Donald Trump says patients buying GLP-1 medicines through TrumpRx are saving $1,800 this year, using a National Diabetes Month message to highlight his administration’s efforts to lower drug costs.

In the message dated 10 November, Trump also predicted that savings would rise to $3,000 by 2028. He did not specify which medicines or comparison prices were used for the figures, or how savings would differ for patients with different insurance coverage.

The White House Council of Economic Advisers used the same figures in a May report, but presented the $1,800 as an expected saving for existing GLP-1 users in 2026. It projected annual savings of $3,000 by 2028. The figures appeared in a discussion of weight-loss drugs sold directly to consumers; the report was not a measurement of what individual patients had saved.

The advisers also reported lower prices for injectable GLP-1 weight-loss medicines, saying they had fallen from $1,000–$1,350 a month to $350 through TrumpRx, with a lower price for starting doses.

TrumpRx, launched in February, directs users to sellers and provides pharmacy coupons rather than selling medicines itself. In July, the Congressional Research Service said people without insurance or buying outside their prescription coverage were most likely to save through the site. It noted that some patients’ insurance co-payments could be lower than the prices listed.